Here are relevant reports on : in-vitro-diagnostics-market
-
Pyrogen Testing Market by Product & Service (Assays, Kits, Reagents, Instruments, Services), Test Type (LAL, Chromogenic, Turbidimetric, Gel Clot, In Vitro, Rabbit), End User (Pharmaceutical, Biotechnology, Medical Device) & Region - Global Forecasts to 2025
The global pyrogen testing market growth is primed to transition from $927 million in 2020 to $1,689 million by 2025, showcasing a strong CAGR of 12.7%. Market drivers include increasing demand for personalized medicine, R&D in pharmaceuticals and biotechnology, rising chronic and infectious diseases, and growing awareness of food safety.
- Published: November 2020
- Price: $ 4950
- TOC Available:
-
In Vitro Toxicology Testing Market by Product (Equipment, Reagents, Kits, Software), Toxicity Endpoints & Type, Technology (Cell Culture, HTS), Method (Cell-based, Computational), Service (Type, Method), Region, Competition - Global Forecast to 2031
The global in vitro toxicology testing market is projected to reach USD 20.97 billion by 2031, growing at a CAGR of 10.6% during the forecast period (2026–2031). The report covers key segments, regional analysis, and competitive landscape across the market ecosystem.
- Published: June 2026
- Price: $ 4950
- TOC Available:
-
Top 10 Medical Device Technologies Market Size, Share & Trends by Type (In Vitro Diagnostics, Diagnostics Imaging, Orthopedic, Ophthalmology, Cardiology, Endoscopy, Diabetes Care, Respiratory Care & Anesthesia, Kidney/Dialysis Devices) and Region - Global Forecast to 2027
The global Top 10 Medical Device Technologies market, valued at US$417.7 billion in 2021, stood at US$437.4 billion in 2022 and is projected to advance at a resilient CAGR of 5.7% from 2022 to 2027, culminating in a forecasted valuation of US$577.5 billion by the end of the period. This growth is driven by trends such as the shift from centralized to point-of-care testing, increasing chronic disease prevalence due to urbanization and lifestyle changes, and growing healthcare needs in emerging economies like India, China, and Brazil.
- Published: May 2023
- Price: $ 8150
- TOC Available:
-
ECU Diagnostics and Testing Market - Global Forecast to 2032
The ECU diagnostics and testing market is projected to grow from USD 18.0 billion in 2025 to reach USD 28.6 billion by 2032. Increasing popularity of hybrid & electric vehicles with complex electrical architectures, increase in demand for advanced features such as ADAS systems for vehicle safety, and rise in demand for in-vehicle experience with entertainment in the vehicle is driving the demand for ECU diagnostics and Testing market during the forecast period.
- Published: July 2026
- Price: $ 4950
- TOC Available:
-
Companion Diagnostics Market - 2019 By Types, Application & Geography
- Published: July 2026
- Price: $ 4950
- TOC Available:
-
Epigenetic Drugs & Diagnostics Market - Global Forecast to 2030
Epigenetic Drugs & Diagnostics Market
- Published: July 2026
- Price: $ 4950
- TOC Available:
-
Medical Device Plastics Market by Material (Standard Plastics, Engineering Plastics), Source, Manufacturing Process (Extrusion, CNC Machining, Injection Molding), Application (Diagnostics Equipment, Surgical Instruments), & Region - Global Forecast to 2030
The medical device plastics market is projected to reach USD 31.82 billion by 2030 from USD 21.93 billion in 2025, at a CAGR of 7.7% from 2025 to 2030. Prominent companies include Jabil Inc. (US), Phillips Medisize (US), Donatelle Plastics, LLC (US), Spectrum Plastics Group (US), Bemis Manufacturing Company (US), Nolato (Sweden), Trelleborg AB (Sweden), Freudenberg Medical (US), Viant (US), and SMC Ltd. (US).
- Published: November 2025
- Price: $ 4950
- TOC Available:
-
Top 10 Automotive Technologies Market (Global Vehicle Intelligence, On Board Internet Services, Remote Diagnostics, HUD, Biometric Vehicle Access, Vehicle Security, 3D Printing, Night Vision, BDS, LDWS), and Region - Global Forecast to 2021
The top 10 automotive technologies are projected to grow at a CAGR of 17.35%, to reach a market size of USD 139.02 Billion by 2021. Increase in demand for luxury vehicles with advance technologies is driving the market for Top 10 Automotive technologies. Also, Government Regulations towards safety feature has propelled growth of automotive technologies. The major players in top 10 automotive technologies market are Delphi Automotive PLC (U.K.), Continental AG (Germany), Robert Bosch GmbH (Germany), and some on board internet service providers are Agero (U.S.), Airbiquity (U.S.), and WirelessCar (Sweden). The major telecom companies which provide connectivity for on board internet services are AT&T (U.S.), Verizon (U.S.), and Vodafone (U.K.).
- Published: February 2017
- Price: $ 4950
- TOC Available:
-
Lymphedema Diagnostics Market by Technology (Lymphoscintigraphy, MRI, Near IR Fluorescence Imaging, Ultrasound), Disease Type (Cancer, Inflammatory Diseases, Cardiovascular, Filariasis), End User (Hospitals, Diagnostic Centers) - Global Forecasts to 2024
The Lymphedema Diagnostics Market is expected to grow from USD 24 million in 2019 to USD 35 million by 2024, at a CAGR of 7.4% during the forecast period. The major players operating in the lymphedema diagnostics market are GE Healthcare (US), Philips (Netherlands), and Siemens Healthineers (Germany). Other prominent players in this market include Canon, Inc. (Japan), Shimadzu Corporation (Japan), Stryker Corporation (US), Fluoptics (France), United Imaging Healthcare Co., Ltd. (China), Hitachi, Ltd. (Japan), Esaote, SpA (Italy), Neusoft Corporation (China), Mindray Medical International, Ltd. (China), Mitaka USA, Inc. (US), Curadel, LLC (US), and ImpediMed Ltd. (Australia).
- Published: October 2019
- Price: $ 4950
- TOC Available:
-
C – Reactive Protein Testing Market by Assay Type (ELISA, Turbidimetric, Immunoturbidimetric), Application (Cardiovascular, Inflammatory Disease, Rheumatoid Arthritis, Cancer), End User (Hospitals, Clinics, Diagnostics Labs) - Global Forecast to 2023
The Global C-Reactive Protein Testing market is expected to reach USD 1.75 billion by 2023 from USD 1.62 billion in 2018, growing at a CAGR of 1.5 % from 2018 to 2023. Growing occurrences of Non Communicable Diseases (NCDs) such as Cardiovascular Diseases, Diabetes and other inflammatory diseases are the major drivers for this market. Point of Care technology for CRP testing is also being used for diagnostic purposes.
- Published: July 2026
- Price: $ 4950
- TOC Available:
Records 31 to 40 of 50
